Navigation Links
Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
Date:9/26/2007

0 Best Companies to Work for" in the United States.

With many established products and services helping patients in nearly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields, as well as immune disease, infectious disease, and other areas of unmet medical need.

About Bayer Schering Pharma

The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma AG. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at http://www.bayerhealthcare.com .

Bayer Schering Pharma is a worldwide leading specialty pharmaceutical company. Its research and business activities are focused on the following areas: Diagnostic Imaging, Hematology/Cardiology, Oncology, Primary Care, Specialized Therapeutics and Women's Healthcare. With innovative products, Bayer Schering Pharma aims for leading positions in specialized markets worldwide. Using new ideas, Bayer Schering Pharma aims to make a contribution to medical progress and strives to improve the quality of life. Find more information at http://www.baye
'/>"/>

SOURCE Genzyme Corporation; Bayer Schering Pharma AG
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
2. Genzyme Announces Results of Clinical Trial of Hylastan
3. Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
4. Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
5. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
6. Genzyme Announces Successful Completion of Study Investigating Sevelamer Carbonate in Patients With Chronic Kidney Disease
7. Schering-Plough Announces Hepatitis C Data Presentations at Digestive Disease Week (DDW) 2007 Annual Meeting
8. Schering-Plough Addresses Major Milestones and Challenges in Treatment of Patients With Chronic Hepatitis C
9. Schering-Plough Announces Presentation of Phase II Trial Results for Novel Oral Thrombin Receptor Antagonist at the 2007 Annual Meeting of The American College of Cardiology/i2 Summit
10. Sygnis Pharma AG announces date for presentation of clinical results
11. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 2015 Eli Lilly and Company (NYSE: ... was statistically superior to placebo in the treatment of ... the proportion of patients achieving an ACR 20 response. ... 20 percent reduction in disease signs and symptoms as ... During the 24-week, Phase 3 study, titled SPIRIT-P1, patients ...
(Date:4/20/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... the development of oral drug delivery systems, announced today ... GTC Diabetes Summit, in the 8 th Diabetes ... 2015 in Boston . Dr. ... a session titled "Early Clinical Impressions of Oral Insulin ...
(Date:4/20/2015)... 20, 2015  ULURU Inc. (OTCQB: ULUR) announced ... with Inter-Mountain Capital Corporation ("Inter-Mountain") to resolve the ... Under the terms of the settlement, ... issued an unsecured Promissory Note for $550,000, and ... of Common Stock at an exercise price of ...
Breaking Medicine Technology:Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 2Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 3Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 4Oramed to Present at the GTC Diabetes Summit 2Oramed to Present at the GTC Diabetes Summit 3ULURU Inc. Announces the Settlement of Outstanding Litigation 2
... Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today that it has ... Foundation for Parkinson,s Research (MJFF) to support studies in non-human primates for ... $900,000 award will be paid over a period of two ... Sangamo has ...
... July 1 Watson Pharmaceuticals, Inc. (NYSE: ... settlement with Novartis Pharmaceuticals Corporation, Novartis Pharma AG, Novartis ... "Novartis"), Watson has commenced shipment of a generic version ... capsules.  Exelon® is used to treat dementia (a brain ...
Cached Medicine Technology:Sangamo BioSciences Receives Michael J. Fox Foundation Funding to Develop Novel Drug for the Treatment of Parkinson's Disease 2Sangamo BioSciences Receives Michael J. Fox Foundation Funding to Develop Novel Drug for the Treatment of Parkinson's Disease 3Sangamo BioSciences Receives Michael J. Fox Foundation Funding to Develop Novel Drug for the Treatment of Parkinson's Disease 4Watson Launches Generic Exelon® 2Watson Launches Generic Exelon® 3
(Date:4/20/2015)... Burlington, Vt. (PRWEB) April 20, 2015 ... environmental networks, is excited to announce that Kate Williams, the ... CEO, effective May 1, 2015. , Williams has been part ... nearly decade-long tenure as Executive Director of the Northern Forest ... Williams has dedicated her career to the stewardship of and ...
(Date:4/20/2015)... 2015 Today the members of ... Fund-Ovarian Cancer National Alliance-National Ovarian Cancer Coalition Translational ... will focus on “DNA Repair Therapies for Ovarian ... DNA repair as a common weakness in ovarian ... early detection of ovarian cancer by developing a ...
(Date:4/20/2015)... Grateful Dead originally formed in 1965 ... 1995. The group was more than just about rock music. ... space rock, country, and other genres to put together their ... The group was inducted into the Rock and Roll Hall ... than 35 million records worldwide. This year marks the ...
(Date:4/20/2015)... Westchester County, New York (PRWEB) April 20, 2015 ... that the Centers for Medicare & Medicaid Services introduced ... of their HCAHPS (Hospital Consumer Assessment of Healthcare Providers ... This national survey asks patients about their experiences during ... current survey results from July 1, 2013 through June ...
(Date:4/20/2015)... Insuranceautoquote.info has released a new blog post ... online . , Affordable auto insurance quotes can ... should always compare online car insurance rates in their ... website: . http://insuranceautoquote.info , The process is ... in a few minutes and the search engine offers ...
Breaking Medicine News(10 mins):Health News:1% for the Planet Announces New CEO 2Health News:1% for the Planet Announces New CEO 3Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 2Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 3Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 4Health News:Grateful Dead Tickets at Levi’s Stadium in Santa Clara: Ticket Down Slashes Grateful Dead Tickets in Santa Clara @ Levi’s Stadium for "Fare Thee Well" 50th Anniversary 2Health News:Northern Westchester Hospital Named a 5-Star Hospital In Medicare's Patient Satisfaction Rating 2Health News:Northern Westchester Hospital Named a 5-Star Hospital In Medicare's Patient Satisfaction Rating 3Health News:Affordable Auto Insurance Quotes Can Be Found Online, Fast and Easy 2
... Blue Distinction Centers,for Complex and Rare Cancers(SM), CHICAGO, ... the overall quality of healthcare in America, Blue Cross ... Today, Blue Cross and Blue Shield members have ... Complex and Rare Cancers across 33,states. With this expansion, ...
... Inc. (Nasdaq: ALXN ) today announced that Leonard ... at,two upcoming investor conferences, one sponsored by Cowen and ... will present at the Cowen and Company 27th Annual ... Tuesday, March 18, 2008.,Dr. Bell will also present at ...
... Granite State Manufacturing (GSM),a New Hampshire-based ... acquired Scandia Manufacturing Company Inc. (Scandia),a leading ... systems,for the Department of Defense. The acquisition ... States Navy., Granite State Manufacturing plans ...
... March 11 Pepperdine,University,s Graziadio School of ... to a MBA business plan addressing California,s ... Mara Kamins, Nurse,Education Web, a web-based clinical ... place in the Pepperdine University Fourth Annual,Business ...
... Education at ... ... 11 ,GetWellNetwork, Inc., a leading provider of Interactive Patient Care ... today announced a partnership to co-develop a comprehensive,suite of pediatric ...
... 11 EaglePicher,Medical Power, a leading supplier of ... that Joseph (Joe) Marotta has,joined the company as ... this position, Mr. Marotta will be responsible for ... including customer,development initiatives. EaglePicher,s medical division has seen ...
Cached Medicine News:Health News:Blue Cross and Blue Shield's Blue Distinction(R) Designation Improves Healthcare by Focusing on Quality 2Health News:Blue Cross and Blue Shield's Blue Distinction(R) Designation Improves Healthcare by Focusing on Quality 3Health News:Blue Cross and Blue Shield's Blue Distinction(R) Designation Improves Healthcare by Focusing on Quality 4Health News:Granite State Manufacturing Acquires Scandia Manufacturing Company Inc. 2Health News:Pepperdine Business Plan Competition Awards $26,000 to MBA Teams 2Health News:Pepperdine Business Plan Competition Awards $26,000 to MBA Teams 3Health News:GetWellNetwork and KidsHealth Partner to Empower Pediatric Patients and Their Families 2Health News:GetWellNetwork and KidsHealth Partner to Empower Pediatric Patients and Their Families 3Health News:GetWellNetwork and KidsHealth Partner to Empower Pediatric Patients and Their Families 4Health News:EaglePicher Medical Power Names Joseph Marotta Vice President of Sales and Marketing 2
... The Titan™ Inflatable Penile ... system designed to be surgically ... the management of erectile dysfunction ... implant provides the patient with ...
... The Alpha I continues to be a ... the Alpha I to have mechanical reliability ... on first-time implants. ioflex material contributes to ... I. Thats because Bioflex: ,Provides maximum, controlled ...
... advanced three-part inflatable prosthesis consisting of a reservoir ... the scrotum and a pair of cylinders inserted ... look and performance of a natural erection. The ... AMS 700 Series now features the new Tactile ...
Only Mentors reusable Alpine Leg Bag has patented Kraylex odor barrier, offset port options, and integrated loops providing total confidence and comfort....
Medicine Products: